Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

The combination of filgrastim (G-CSF) and plerixafor is currently approved for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin lymphoma and multiple myeloma undergoing autologous peripheral blood hematopoietic cell transplantation. However, chemotherapy and G-CSF-based mobi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Awan, Farrukh T., Kochuparambil, S. Thomas, DeRemer, David, Cumpston, Aaron, Craig, Michael, Jillella, Anand, Hamadani, Mehdi
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3335320/
https://ncbi.nlm.nih.gov/pubmed/22570654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/931071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados